首页 | 本学科首页   官方微博 | 高级检索  
     


DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamide
Authors:R. F. Struck  R.L. Davis Jr.  M. D. Berardini  E. L. Loechler
Affiliation:(1) Southern Research Institute, P.O. Box 55305, Birmingham, AL 35255-5305, USA Fax: +1-205-5812877, US;(2) Department of Biology, Boston University, Boston, MA, USA, US
Abstract:Purpose: The purpose of this investigation was to determine the base sequence specificity of isophosphoramide mustard (IPM), the alkylating metabolite of ifosfamide, by crosslinking of designed DNA oligomers in comparison with the clinical alkylating agents mechlorethamine (ME) (nitrogen mustard) and phosphoramide mustard (PM), the alkylating metabolite of cyclophosphamide. Methods: IPM, as well as PM and ME were each reacted with three dodecameric duplexes, which were designed to detect interstrand crosslinking between guanines in 5′-GC-3′ (I), 5′-GNC-3′ (II) or 5′-GNNC-3′ (III) sequences (N=A or T). Results: All three agents preferentially react with 5′-GNC-3′ target sequences. The 5′-GNNC-3′ target sequence is less reactive by a factor of approximately 2.5- to 10-fold, while 5′-GC-3′ is of even lower reactivity. Conclusion: These results indicate that all three agents show approximately equal preference for reaction with a 5′-GNC-3′ target sequence in spite of the fact that IPM yields a 7-atom crosslink, while the other two agents yield 5-atom crosslinks. Received: 9 February 1999 / Accepted: 21 June 1999
Keywords:DNA  Crosslinking  Isophosphoramide mustard
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号